351 related articles for article (PubMed ID: 33760368)
1. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology.
Liu S; Liu Y; Wu X; Liu Z
J Orthop Surg Res; 2023 Oct; 18(1):769. PubMed ID: 37821971
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics approach by
Zhang Y; Zhang H; Chang D; Guo F; Pan H; Yang Y
Arthritis Res Ther; 2018 Jun; 20(1):111. PubMed ID: 29871692
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
Wang M; Li R; Qi H; Pang L; Cui L; Liu Z; Lu J; Wang R; Hu S; Liang N; Tao Y; Dalbeth N; Merriman TR; Terkeltaub R; Yin H; Li C
Arthritis Rheumatol; 2023 Dec; 75(12):2252-2264. PubMed ID: 37390372
[TBL] [Abstract][Full Text] [Related]
5. Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients.
Liu S; Wang Y; Liu H; Xu T; Wang MJ; Lu J; Guo Y; Chen W; Ke M; Zhou G; Lu Y; Chen P; Zhou W
Rheumatology (Oxford); 2022 May; 61(6):2644-2651. PubMed ID: 34599805
[TBL] [Abstract][Full Text] [Related]
6. The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics.
Wu X; You C
PeerJ; 2023; 11():e14554. PubMed ID: 36632144
[TBL] [Abstract][Full Text] [Related]
7. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
8. A metabonomic study to explore potential markers of asymptomatic hyperuricemia and acute gouty arthritis.
Wang W; Kou J; Zhang M; Wang T; Li W; Wang Y; Xie Q; Wei M
J Orthop Surg Res; 2023 Feb; 18(1):96. PubMed ID: 36782295
[TBL] [Abstract][Full Text] [Related]
9. Levels of Cytokines and MicroRNAs in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench-to-Bedside Approach.
Estevez-Garcia IO; Gallegos-Nava S; Vera-Pérez E; Silveira LH; Ventura-Ríos L; Vancini G; Hernández-Díaz C; Sánchez-Muñoz F; Ballinas-Verdugo MA; Gutierrez M; Pineda C; Rodriguez-Henriquez P; Castillo-Martínez D; Amezcua-Guerra LM
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1814-1821. PubMed ID: 29457379
[TBL] [Abstract][Full Text] [Related]
10. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
[TBL] [Abstract][Full Text] [Related]
11. Plasma Metabolomics Reveals Systemic Metabolic Alterations of Subclinical and Clinical Hypothyroidism.
Shao F; Li R; Guo Q; Qin R; Su W; Yin H; Tian L
J Clin Endocrinol Metab; 2022 Dec; 108(1):13-25. PubMed ID: 36181451
[TBL] [Abstract][Full Text] [Related]
12. Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry.
Li Q; Wei S; Wu D; Wen C; Zhou J
Biomed Res Int; 2018; 2018():3461572. PubMed ID: 30410926
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiles delineate the effect of Sanmiao wan on hyperuricemia in rats.
Jiang T; Qian J; Ding J; Wang G; Ding X; Liu S; Chen W
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27450803
[TBL] [Abstract][Full Text] [Related]
15. Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study.
Ohashi Y; Ooyama H; Makinoshima H; Takada T; Matsuo H; Ichida K
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397902
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction.
Bahado-Singh RO; Yilmaz A; Bisgin H; Turkoglu O; Kumar P; Sherman E; Mrazik A; Odibo A; Graham SF
PLoS One; 2019; 14(4):e0214121. PubMed ID: 30998683
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
18. Untargeted metabolomics yields insight into ALS disease mechanisms.
Goutman SA; Boss J; Guo K; Alakwaa FM; Patterson A; Kim S; Savelieff MG; Hur J; Feldman EL
J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1329-1338. PubMed ID: 32928939
[TBL] [Abstract][Full Text] [Related]
19. Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia.
Luo Y; Wang L; Liu XY; Chen X; Song YX; Li XH; Jiang C; Peng A; Liu JY
Amino Acids; 2018 Nov; 50(11):1539-1548. PubMed ID: 30073607
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
